P16-54 LB. Blood CCR6+ Th17 and Th1Th17 but not CCR6neg Th1 cells are targets for HIV replication and their frequency is diminished in HIV-infected subjects

por Gosselin, A, Monteiro, P, Chomont, N, Diaz-Griffero, F, Wacleche, VS, Said, EA, Fonseca, S, El-Far, M, Boulassel, M, Routy, J, Sekaly, R, Ancuta, P
Publicado 2009

OA04-05. Safety and viral load changes in HIV-1 infected subjects treated with autologous dendritic immune therapy following ART discontinuation (CTN#239)

por Routy, J, Boulassel, M, Mona, L, Sylvie, V, Cécile, T, Jonathan, A, John, G, Jean-Guy, B, Fiona, S, Renu, J, Don, H, Irina, T, Charles, N, Sékaly, RP
Publicado 2009

P18-13 LB. Immunogenicity of an autologous dendritic cell anti-HIV therapy in HIV-1 infected individuals

por Yassine Diab, B, Coutsinos, Z, Landry, C, Gagnon, D, Sauvé, D, Hébert-Benoît, C, Hébert, V, Boulassel, M, Routy, J, Jain, R, Tcherepanova, I, Healey, D, Nicolette, C, Sekaly, R
Publicado 2009